C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12876-015-0333-z
Published Online: 2015-08-14
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Iwasa, Ryota
Yamada, Akihiro
Sono, Koji
Furukawa, Ryuichi
Takeuchi, Ken
Suzuki, Yasuo
License valid from 2015-08-14